Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.

Nature cancerยท2026
Same author

Paratonia in Advanced Dementia: A Frequently Misunderstood Movement Disorder.

Journal of the American Medical Directors Associationยท2026
Same author

Uveitis Management at the Crossroads of Pharmacotherapy, Nanotechnology, and Intellectual Property.

ACS applied bio materialsยท2026
Same author

The Yield of Staging Investigations in Patients with Breast Cancer Planned for Neoadjuvant Chemotherapy.

Current oncology (Toronto, Ont.)ยท2026
Same author

Ophthalmic manifestations and management of Traboulsi syndrome in three children of a Saudi family.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Societyยท2026
Same author

Fuzzy fractional modeling and analysis of stochastic Fokker Planck equations under uncertainty and memory effects.

Scientific reportsยท2026

Related Experiment Video

Updated: Jun 25, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

What can be learned from open direct comparative trials in multiple sclerosis?

Omar Khan1

  • 1School of Medicine, Wayne State University, Detroit, MI, USA. okhan@med.wayne.edu

Journal of the Neurological Sciences
|February 10, 2009
PubMed
Summary

Well-designed observational studies in multiple sclerosis (MS) offer valid treatment effect estimates comparable to randomized controlled trials (RCTs). These studies, like one comparing interferon-beta and glatiramer acetate, provide reliable data for comparing MS therapies.

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Related Experiment Videos

Last Updated: Jun 25, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Area of Science:

  • Clinical Research Methodology
  • Neuroimmunology

Background:

  • Randomized controlled trials (RCTs) are the gold standard, but observational studies are increasingly recognized for their validity.
  • Observational studies under real-world conditions validate RCT findings and assess treatment representativeness.
  • Multiple sclerosis (MS) research increasingly utilizes observational studies to compare disease-modifying therapies (DMTs).

Purpose of the Study:

  • To evaluate the comparative effectiveness and tolerability of high-dose interferon-beta and glatiramer acetate in relapsing-remitting MS.
  • To demonstrate the utility of well-designed observational studies in generating reliable clinical research data.
  • To support the use of observational studies as a cost-effective alternative for hypothesis testing in MS.

Main Methods:

  • A prospective observational study involving 156 patients with relapsing-remitting MS.
  • Comparison of high-dose interferon-beta and glatiramer acetate treatments.
  • Evaluation of efficacy across all measured outcomes.

Main Results:

  • High-dose interferon-beta and glatiramer acetate demonstrated similar efficacy in all evaluated measures.
  • Observed effect sizes were comparable to those from pivotal trials of these MS therapies.
  • Findings align with later, larger randomized studies showing no significant difference between the treatments.

Conclusions:

  • Well-designed observational studies provide valid and reliable data on treatment effects in multiple sclerosis.
  • These studies can serve as a cost-effective method for preliminary hypothesis testing.
  • Given the challenges of RCTs, open-label or rater-blinded observational designs will be increasingly important for comparing MS therapies.